Full Text View
Tabular View
No Study Results Posted
Related Studies
A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)
This study has been completed.
Study NCT00336713   Information provided by Sanofi

First Received on June 13, 2006.   Last Updated on July 28, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depressive Disorder
Additional conditions recognized in this trial
Depression
Depressive Disorder, Major
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
Saredutant (SR48968C)
Placebo
Additional drug interventions recognized in this trial
Antidepressive Agents
More general drug interventions related to this trial
Central Nervous System Agents
Pharmacologic Actions
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services